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Background: Diagnostic techniques based on PCR for the detection of Plasmodium DNA can be highly sensitive
and specific. The vast majority of these techniques rely, however, on the invasive sampling of blood from infected
hosts. There is, currently, considerable interest in the possibility of using body fluids other than blood as sources of
parasite DNA for PCR diagnosis.
Methods: Urine and faeces were obtained from a Plasmodium knowlesi infected-Japanese macaque (Macaca fuscata)
over the course of an experimentally induced infection. P. knowlesi DNA (PkDNA) extracted from urine and faeces were
monitored by nested PCR targeting the P. knowlesi specific cytochrome b (cytb) gene.
Results: Urinary PkDNA was detected on day 2, but was not amplified using DNA templates extracted from the
samples on day 4, day 5 and day 6. Subsequently, urinary PkDNA was detected from day 7 until day 11, and from
day 20 until day 30. PkDNA in faeces was detected from day 7 until day 11, and from day 20 until day 37.
Moreover, real-time quantitative PCR showed a remarkable increase in the amount of urinary PkDNA following
anti-malarial treatment. This might have been due to the release of a large amount of PkDNA from the degraded
parasites as a result of the anti-malarial treatment, leading to excretion of PkDNA in the urine.
Conclusions: The cytb-PCR system using urine and faecal samples is of potential use in molecular
epidemiological surveys of malaria. In particular, monkey faecal samples could be useful for the detection of
zoonotic primate malaria in its natural hosts.
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To date, microscopic examination of Giemsa-stained
blood smears remains the most common and most trusted
technique for the detection of malaria parasites. There are
many alternative methods for parasite detection, each with
their own strengths and weaknesses compared to micros-
copy. These include various techniques, such as rapid
immuno-chromatographic tests that detect circulating* Correspondence: skawai@dokkyomed.ac.jp
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unless otherwise stated.malaria antigens or antibodies; and polymerase chain reac-
tion (PCR)-based assays for the detection of parasite DNA
in peripheral blood [1]. Although these techniques are now
available for diagnosing malaria, current approaches rely on
the drawing of blood by finger pricking or venipuncture.
The requirement for repeated drawing of blood samples for
longitudinal follow-up studies or continuous monitoring in
the case of vaccine efficacy tests may at times result in poor
compliance, especially among infants, young children and
pregnant women [2]. In addition, the procedure for draw-
ing blood, if not carried out under stringent conditions, is
associated with the risk of acquiring needle-bornetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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deficiency virus [3]. Therefore, the development of nonin-
vasive approaches using body fluids other than blood
would improve malaria diagnosis and the completion of
epidemiological surveys. It is also likely that noninvasive
approaches to surveillance would improve population
coverage.
Plasmodium knowlesi is a simian malaria parasite the
natural hosts of which long-tailed macaques (Macaca
fascicularis), pig-tailed macaques (Macaca nemestrina),
and banded leaf monkeys (Presbytis malalophos), all of
which inhabit large areas of Southeast Asia [4]. Following
the report in 2004 of a large focus of human infections
with P. knowlesi in Peninsular Malaysia, zoonotic P. know-
lesi infections were described from numerous countries in
Southeast Asia [4,5]. Human P. knowlesi infection may
often have been misidentified by microscopy as Plasmo-
dium malariae or Plasmodium falciparum due to mor-
phologic similarities, leading to underestimations of its
true prevalence [4]. Thus, PCR-based assays and sequence
analysis are probably the most reliable methods of identi-
fying P. knowlesi infection. Wide-scale surveys based on
PCR are required to assess the prevalence and distribution
of the reservoir hosts of zoonotic primate malaria. To
date, epidemiological surveys involving the natural hosts
of P. knowlesi rely on the detection of parasite DNA ex-
tracted from fresh, frozen or dried blood obtained from
wild monkeys [6,7]. As invasive sampling of non-human
primates is problematic both practically and ethically,
non-invasive sampling methods are desirable.
Recent studies have shown that the saliva, urine and
faeces of malaria patients contain trace amounts of Plas-
modium DNA that is amplifiable by PCR and, therefore,
could be used as an alternative source of specimens for
epidemiological surveys [8-13]. Detection of parasite
DNA fragments in urine by PCR has also been employed
in the diagnosis of various other parasitic diseases, such
as those caused by Toxoplasma gondii, Leishmania spp.,
Trichomonas vaginalis, Entamoeba histolytica, and
Schistosoma mansoni, although at present it is still not
widely used [14-18]. Despite the lower sensitivity of PCR
for the detection of parasite DNA from urine and faeces
compared to blood, noninvasive sampling may be prefer-
able due to ease of use. Moreover, if parasite DNA can
be detected using the excreta of free-living monkeys, it
will provide a useful tool for epidemiological surveys on
zoonotic primate malaria. Here, the detection of P.
knowlesi DNA (PkDNA) in urine and faeces obtained
from a Japanese macaque (Macaca fuscata) over the
course of an experimentally induced infection is demon-
strated. The relationship between parasitaemia and the
detection of PkDNA in both faeces and urine is analysed,
and the diagnostic performance of PkDNA detection is
assessed.Methods
Animals and infection procedure
A four-year-old 5.0 kg female Japanese macaque
(Macacca fuscata), a second-generation offspring bred
in captivity that had never been infected with malaria
parasites, was used for this study. The animal was kept
in an individual cage in a controlled environment at 25-
27°C and 30-60% humidity, and given commercial food
pellets supplemented with fresh fruits. Throughout the
course of the experiment, investigators adhered to the
Guidelines for the Use of Experimental Animals autho-
rized by the Japanese Association for Laboratory Animal
Science. The protocol was approved by the Committee
on the Ethics of Animal Experiments of Dokkyo Medical
University (Permit Number: 0656). The monkey was
inoculated intravenously with 1×109 frozen P. knowlesi
H strain (ATCC No. 30158) parasitized red blood cells
(PRBCs) obtained from another infected Japanese ma-
caque. Thin blood films were prepared from peripheral
blood obtained through earpick at day 0, 2, 4, 5, 6, 7, 8,
9, 11, 15, 20, 21, 22, 23, 25, 30, 37, 40, 50, and 60. Fol-
lowing Giemsa staining, parasitaemia was counted in a
total 104 erythrocytes with an optical microscope. Hepa-
rinized blood samples for DNA extraction and
hematological examinations were obtained intravenously
from the infected monkey on day 0, 2, 4, 6, 7, 9, 11, 15,
20, 25, 30, 37, 40, 50, and 60. Whole blood samples for
DNA extraction were stored at −80°C until DNA
extraction.
Sampling procedures for urine and faeces
Urine and faecal samples for DNA extraction were ob-
tained from the infected monkey on days 0, 2, 4, 5, 6, 7,
8, 9, 10, 11, 12, 15, 20, 21, 22, 25, 30, 37, 40, 50, and 60.
A sampling net and tray were set under the monkey
cage for three hours in the morning (9:00 AM-
12:00 PM) from which fresh urine and faeces were col-
lected from the infected monkey (Additional file 1).
They were replaced and cleaned thoroughly after every
sampling to avoid contamination. Negative control sam-
ples were obtained from two non-infected monkeys (ID:
J83 and J84) according to the same procedures. One
gram of fresh faeces was mixed with 2.0 mL RNAlaterW
solution (AmbionW, Austin, TX), and the faecal and
urine samples were promptly stored at −80°C until DNA
extraction. After thawing the urine samples, haemoglo-
bin concentrations were measured using a commercial
kit (Wako Pure Chemical Industries, Ltd., Osaka Japan).
Bleeding due to menstruation was not observed during
the experimental period.
Anti-malarial treatment
On the 7th day post-infection, an injectable solution of
chloroquine sulphate 40 mg (NIVAQUINE™; Bangladesh
Kawai et al. Malaria Journal 2014, 13:373 Page 3 of 9
http://www.malariajournal.com/content/13/1/373Pharmaceutical Industry Lit, Dhaka, Bangladesh) was
administered intramuscularly, followed by 20 mg at 6 hr,
24 hr and 48 hr after initial administration for a total of
100 mg (Figure 1). Parasitaemia dropped to sub-
microscopic levels from day 9 post-infection (two days
following first drug treatment), but recrudesced at day
20 post-infection. On day 20 post-infection, 40 mg of
NIVAQUINE™ was administered, followed by 20 mg at
6 hr, 12 hr, 24 hr and 48 hr after first administration.
On days 23, 24, 25 and 26, 20 mg of NIVAQUINE™ was
administered to prevent recrudescence of the parasite
(Figure 1).
DNA extraction steps
DNA was extracted from 100 μL of each whole blood
sample by using the Illustra™ blood genomicPrep Mini
Spin Kit (GE Healthcare, Buckinghamshire, UK) accord-
ing to the manufacturer’s instructions, and then eluted
into 200 μL of elution buffer for the kit. DNA extraction
from urine samples was performed with a QIAamp®
Viral RNA Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s instructions. Briefly, 4 mL of
urine sample was applied to the centrifugal filter units
(Amicon Ultra-15, Millipore Ireland B.V., County Cork,
Republic of Ireland), followed by centrifugation for
10 minutes at 2,000× g. 200 μL of the concentrated
samples were applied to QIAam® spin columns and cen-
trifuged. After two washes, DNA was eluted with 80 μL
of the supplied buffer at room temperature. DNA extrac-
tion from faecal samples (1 g of faeces/2 ml RNAlate®)
was performed with QIAamp® DNA Stool Mini Kit
(Qiagen) according to the manufacturer’s instructions,
and then eluted into 50 μL of elution buffer for the kit.
DNA extractions from each sample were performedFigure 1 Parasitaemia during the course of infection. The arrows indic
blood by microscopy.within one month of the sampling, and the purity and
concentration of DNA samples were determined using
NanoDrop apparatus (Thermo Fisher Scientific, Waltham,
MA). DNA was stored at −20°C until use.
Nested PCR for amplification of PkDNA
Nested PCR (nPCR) was performed using a TaKaRa PCR
Thermal Cycler Dice (TAKARA BIO INC. Shiga, Japan).
Detection of PkDNA in blood, urine and faeces was
performed by nPCR targeting the mitochondrial
cytochrome b gene (cytb). Primers for the primary PCR
were Plasmodium genus-specific and those for second-
ary PCR were specific for P. knowlesi. Forward primers
for the primary and secondary PCRs were as reported
by Putaporntip et al. and the reverse primers were as
reported by Tanizaki et al. [12,19]. DNA amplification
was carried out in a total volume of 20 μL containing
1 μL of DNA template, 10 μL of 2X PCR buffer
(AmpliTaq Gold PCR Master Mix, AB Applied
Biosystems, Branchburg, NJ, USA), and 0.3 μM of each
primer. Final volume of original samples per each PCR
was as follows; blood was 0.5 μL; urine was 50 μL;
faeces was 50 mg. Primary amplification conditions
were as follows: initial denaturation at 95°C for 5 min,
followed by 35 cycles (94°C for 40 sec, 50°C for 30 sec
and 72°C for 30 sec) and final extension at 72°C for
4 min. The product was diluted 1:50 in DEPC treated
water (Invitrogen, Carlsbad, CA, USA), and 2 μL of the
diluted product was subsequently subjected to secondary
amplification. The concentration of the primers and other
constituents for secondary amplification was identical to
those of the primary amplification. Secondary amplification
conditions consisted of 25 cycles under the same condi-
tions as the primary PCR, followed by a final extension atate chloroquine treatment. : Parasite negative in peripheral
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visualized by gel electrophoresis on a 2% agarose gel.
Real-time quantitative PCR
To measure the amount of PkDNA in the urine after
anti-malarial treatment, quantitative nested real-time PCR
(qPCR) was carried out. The qPCR in this study was
designed referring to a previous report on diagnosis of
Barmah forest virus infection by a nested real-time SYBR
green RT-PCR assay [20]. Urine samples for qPCR were
collected from the monkey prior to and following admin-
istration of the first and second anti-malarial treatment
(Figure 1). The first set of urine samples was collected on
day 5, day 6, 10:00 on day 7, 16:00 on day 7, 10:00 on day
8 and on day 10, and the second set of urine samples was
collected on day 19, 10:30 on day 20, 16:30 on day 20,
10:30 on day 21, day 22 and day 23. qPCR was conducted
using the first PCR products obtained from genus specific
PCR used as a DNA template. All samples were tested in
triplicate. The PCR mix consisted of 12.5 μL SYBR®
Premix Ex Taq™ II, Tli RNaseH Plus (TAKARA BIO
INC.), 0.4 μM of each primer (e.g., PkCBF and PkCBR-ed)
[12,19], and 2 μL of template DNA in a 25 μL final reac-
tion mix. PCR was performed in a Thermal Cycler Dice®,
Real Time System II (TAKARA BIO INC.) under the fol-
lowing conditions: 30 seconds at 95°C for initial denatur-
ation, followed by 40 cycles (95°C for 5 sec and 50°C for
30 sec) with melting curve analysis (95°C for 15 sec, 60°C
for 30 sec and 95°C for 15 sec).
Standard curve for qPCR
To produce the standard curve for qPCR, genomic DNA
of P. knowlesi H strain was prepared from infected blood
obtained from another P. knowlesi-infected monkey (ID:
J60). Parasitaemia in the blood was determined as 27%.
DNA extraction from infected blood was performed
with the Illustra™ blood genomicPrep Mini Spin Kit
according to the manufacturer’s instructions. Final
concentration of DNA dissolved in 200 μL TE buffer
was 57.6 ng/μL. The DNA solution was diluted 1:1,000
with TE buffer, which was defined as 104 “Plasmodial
units (P units)”. The standard curve for PkDNA was
obtained from five serial dilutions (57.6 ng/μL ×1,
57.6 ng/μL ×10−1, 57.6 ng/μL ×10−2, 57.6 ng/μL ×10−3
and 57.6 ng/μL ×10−4). Two negative controls con-
sisted of sterile water. Primers for the first PCR were
used PCBF and PCBR-ed [12,19]. The first PCR was
carried out in a total volume of 20 μL containing 1 μL
of DNA template, 10 μL of 2X PCR buffer (AmpliTaq
Gold PCR Master Mix), and 0.3 μM of each primer.
Primary amplification conditions were as follows:
initial denaturation at 95°C for 5 min, followed by
35 cycles (94°C for 40 sec, 50°C for 30 sec and 72°C for
30 sec) and final extension at 72°C for 4 min. The firstPCR product was diluted 1:50 in DEPC treated water
(Invitrogen), and 2 μL of the diluted product was sub-
sequently subjected to qPCR for the standard curve.
The PCR mix consisted of 12.5 μL SYBR® Premix Ex
Taq™ II, Tli RNaseH Plus (TAKARA BIO INC.),
0.4 μM of each primer (e.g., PkCBF and PkCBR-ed)
[12,19], and 2 μL of template DNA in a 25 μL final
reaction mix. Secondary PCR for the standard curve
was performed same condition as the sample analysis.
Results of the qPCR are expressed in terms of “P
units”.Results
Parasitaemia and clinical examinations
Parasites were first detected in the peripheral blood by
microscopy on day 5 post infection, and, thereafter, parasit-
aemia increased sharply to around 10% on day 7 (Figure 1).
On day 7, parasitaemia decreased markedly after initial
treatment with CQ, and no parasites were detectable in the
peripheral blood by microscopy from day 9 to day 15 post-
infection. However, on day 20, parasitaemia rose to 9.53%,
and the monkey was administered anti-malarial drug once
again (Figure 1). Parasitaemia decreased remarkably after
this second treatment, with no second recrudescence
observed for the remainder of the experiment. For this
experiment, we monitored the kinetics of blood creatinine
(CREA) and blood urea nitrogen (BUN) levels as an indica-
tor of renal function (Table 1). On day 7, CREA and BUN
levels experienced temporarily mild elevations as parasit-
aemia reached its primary peak; thereafter, levels ranged
from 0.46 to 0.62 mg/dL (mean ± SD: 0.55 ± 0.04 mg/dL)
and 10.3 to 18.8 mg/dL (15.1 ± 2.64), respectively. These
concentrations were within the normal range of CREA
(0.81 ± 0.28 mg/dL) and BUN (16.8 ± 5.2 mg/dL) in
Japanese macaques [21]. In addition to blood haemoglobin
levels, we monitored the kinetics of urinary haemoglobin
levels (Table 1). On day 7 and 20, haemoglobin levels in
the urine were elevated, correlating with increase in
parasitaemia and with anti-malarial treatment. Urine
samples that contained high haemoglobin concentrations
showed a reddish colour.Detection of PkDNA from blood, urine and faeces
The infection course was monitored by nPCR using DNA
templates obtained from whole blood, urine and faeces.
PkDNA was first detected in whole blood on day 2, where
it remained detectable until day 25 post-infection (Figure 2).
Urinary PkDNA was detected initially on day 2, but was
not detected on day 4, day 5 and day 6 (Figure 3A). Subse-
quently, PkDNA in urine was detected from day 7 until
day 11, and from day 20 until day 30. Additionally, PkDNA
in the faeces was detected from day 7 until day 11, and
from day 20 until day 37 (Figure 3B). The negative control
Table 1 Results of clinical examination over the course of the experiment
Day after infection
0 4 6 7 9 11 15 20 25 30 37 40 50 60
Para. % - - 0.1 10.08 - - - 9.58 - - - - - -
WBC ×103/μL 5.38 7.04 8.01 5.09 7.61 6.23 5.34 5.80 10.42 4.57 4.19 5.44 5.42 5.84
RBC ×104/μL 512 471 481 403 329 302 327 312 258 327 401 403 452 428
HGB g/dL 14.2 13.2 13.4 11.5 8.9 8.2 9.1 8.9 7.0 9.3 11.3 11.3 12.5 11.9
HCT % 44.4 40.8 41.7 36.6 29.5 26.8 29.2 29.6 24.8 31.1 37.7 37.3 39.1 37.4
MCV FI 86.7 86.6 86.7 90.8 89.7 88.7 89.3 94.9 96.1 95.1 94.0 92.6 86.5 87.4
MCH Pg 27.7 28.0 27.9 28.5 27.1 27.2 27.8 28.5 27.1 28.4 28.2 28.0 27.7 27.8
MCHC % 32.0 32.4 32.1 31.4 30.2 30.6 31.2 30.1 28.2 29.9 30.0 30.3 32.0 31.8
ALB g/dL 4.7 4.4 4.4 3.5 3.3 3.3 3.6 3.1 3.1 3.2 3.9 3.8 4.1 3.9
AST IU/L 27 24 27 51 42 31 24 52 50 25 23 28 30 19
ALT IU/L 52 40 44 42 47 39 509 25 40 31 27 27 32 23
LD IU/L 360 342 342 638 711 611 959 882 1277 533 302 569 489 265
ALP IU/L 790 892 909 704 973 1113 73 932 859 723 690 722 647 640
γ -GTP IU/L 96 84 88 68 70 63 0.51 69 67 72 84 81 90 82
Cr mg/dL 00 0.69 0.66 0.82 0.53 0.46 14.3 0.62 0.54 0.53 0.55 0.58 0.59 0.59
BUN mg/dL 0.67 15.4 16.9 22.2 10.3 11.2 0.1 13.6 16.9 15.1 16.2 18.0 16.6 18.8
BIL mg/dL 13.9 0.1 0.1 0.2 0.1 0.2 0.01 0.05 0.1 0.1 0.1 0.1 0.1 0.1
BRP mg/dL 0.01 <0.01 0.03 7.89 6.26 0.25 0.01 10.40 0.24 0.01 0.01 0.01 <0.01 <0.01
U-HGB* mg/dL 56.8 57.9 58.4 102.0 65.0 65.0 68.3 213.6 62.8 54.5 54.0 60.1 52.8 52.8
U-HG*: Urinary hemoglobin level.
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negative reaction.
Real-time quantitative PCR
The standard curve constructed using five serial dilutions
of the DNA solution showed good linearity with a consist-
ent coefficient (R2 = 0.9892) (Additional file 2A). Melting
curve analysis permitted the clear identification of
PkDNA, as shown additional file 2B, and Tm values for
each sample were highly reproducible during repeated
melt curve runs. The quantity of PkDNA in urine samples0 2 4 6 7 9 11 15 20 2
days after in
M
Figure 2 Detection of PkDNA in peripheral blood over the course of t
N2: negative control for 2nd PCR.collected from the monkey before, during, and after
administration of anti-malarial treatment was measured by
qPCR (Figure 4). The initial anti-malarial treatment started
from 10:00 am on day 7 post-infection when parasitaemia
was 10.08%. The quantity of PkDNA in urine increased
around 50-fold (50.3 P units) 6 hours after initial adminis-
tration (Figure 4A). Furthermore, when parasitaemia was
9.58% (at 10:30 on day 20), a second anti-malarial treat-
ment course was initiated. The quantity of PkDNA in urine
increased around 10-fold (5.0 P units) 6 hours after admin-
istration (Figure 4B). Twenty-four hours from the start of5 30 37 40 50 60 PC N1 N2
fection
he experiment. PC: positive control, N1: negative control for 1st PCR,





Figure 3 Detection of PkDNA in urine (A) and faecal samples (B) over the course of the experiment. PC: positive control, N1: negative
control for 1st PCR, N2: negative control for 2nd PCR.
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PkDNA markedly increased by around 60-fold (297.0 P
units), followed by a concurrent decrease with decreas-
ing parasitaemia.
Comparison between microscopy and nPCR
A summary of parasite detection by microscopy and of
PkDNA by nPCR performed on gDNA extracted from
blood, urine and faeces is shown in Figure 5. The detec-
tion period of the parasite by microscopy was markedlyFigure 4 Kinetics of PkDNA concentration in urine samples. (A): Initial
administration of chloroquine.shorter than the detection of PkDNA using nPCR.
PkDNA in blood, urine and faeces was detectable by
nPCR, even when the erythrocytic stage of the parasite
was not observable by microscopy. Moreover, PkDNA in
faeces was detectable for a longer period than urinary
PkDNA and PkDNA in the blood.
Discussion
Diagnostic techniques based on PCR for the detection of









CQ, im, CQ, im,
0 10 20 30 60
days after infection
: positive reaction
Figure 5 Summary of parasite detection by microscopy and
detection of PkDNA by nPCR. The arrows indicate intramuscular
administration of chloroquine.
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the invasive sampling of blood from infected hosts.
Drawing blood for epidemiological surveys can cause
considerable discomfort [2,3]. Accordingly, follow-up of
patients using a less-invasive approach is desirable when
conducting surveys of malaria prevalence. Recent studies
have reported the detection of P. falciparum DNA
(PfDNA) from saliva, urine and faecal samples, thus pav-
ing the way for a novel alternative source of specimens
for potential malaria diagnosis [8-18]. These studies
show that performing nPCR using PfDNA templates
extracted from noninvasive samples had encouragingly
high sensitivity and specificity, compared with micros-
copy of infected blood. In the present study, we were
able to monitor the presence of PkDNA not only from
blood samples, but also in urine and faeces were
obtained from an infected Japanese macaque during a
malaria episode.
Effective preservation of urine samples from malaria
patients is a key factor influencing the performance of
nPCR [11]. Furthermore, it has been suggested that etha-
nol preservation of urine samples is suitable for sample
collection for field studies [11]. Although, in the present
study, urine samples were not preserved in ethanol, they
were promptly stored at −80°C, and the DNA extrac-
tion step was performed within a month of sampling.
In addition, urine-derived DNA used as a PCR template
was concentrated by centrifugal filter units prior to
DNA extraction. A previous study using qPCR showedthat the quantity of PfDNA detected in human urine
was 2500-fold less than that from blood obtained
concurrently from infected individuals [9]. It is believed
that trace amounts of parasite DNA in urine can be
significantly affected by various external factors such as
microbial contamination and temperature conditions
during sample preservation. It therefore appears that
using suitable preservation methods and carrying out a
DNA concentration step are important for the detec-
tion of parasite DNA in urine.
The release of Plasmodium DNA in urine could be a
general phenomenon that occurs during the course of
infection. However, since Plasmodium DNA may be
released into the urine via various possible routes, the
actual route of entry has not yet been precisely defined. In
the present study, urinary PkDNA was first detected on
day 2 after intravenous inoculation of frozen PRBCs, but
was subsequently not detected on day 4, day 5 and day 6.
The urinary PkDNA seen on day 2 might have consisted
of cell-free DNA from parasites that had degraded due to
damage after thawing in the bloodstream. Moreover,
qPCR results showed that the quantity of PkDNA in the
urine increased markedly following anti-malarial treat-
ment. This might have been due to the release of a large
amount of PkDNA from the parasites that had been
degraded following anti-malarial therapy, leading to excre-
tion of PkDNA in the urine. Therefore, the main source of
Plasmodium DNA in urine is likely to consist of circulat-
ing cell-free DNA originating from dying parasites in per-
ipheral blood. These findings indicate that urine sampling
is potentially useful for detecting malaria cases in longitu-
dinal surveillance during, for example, anti-malarial drug
trials. Although the relationship between low parasitaemia
and urinary PkDNA level during chronic infection was
not assessed here, the presence of PkDNA in the urine
may be explained by the passage of parasite DNA frag-
ments through the glomerulus as a result of normal renal
function. Indeed, the kinetics of both BUN and CREA
levels in the host stayed within their normal range during
the experiment.
The simian parasite P. knowlesi has recently been found
to be a major cause of malaria in humans in Malaysian
Borneo, with the disease also reported in several Southeast
Asian countries [4]. Epidemiological surveys of P. knowlesi
infections in wild monkeys are very important for assessing
the risk of zoonotic malaria. However, few studies exist on
zoonotic primate malaria occurring under natural condi-
tions since it is practically and ethically difficult to obtain
blood samples from wild monkeys [6,7]. Faecal samples
would, therefore, offer an attractive alternative method for
the detection of primate malaria. Recently, phylogenetic
analyses of DNA sequences from Plasmodium spp. have
been conducted from faecal samples obtained from
infected chimpanzees, gorillas, and bonobos [22-24]. The
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nPCR from faecal samples obtained over the course of an
infection. Detection was possible, even when the parasite’s
erythrocytic stage was not observable by microscopy. Our
findings will provide basic data for future field surveys of
P. knowlesi infection in free-living monkeys.
PkDNA in the blood was detected from day 2 until day
25 post-infection. As DNA was extracted from whole
blood containing RBCs and sera, DNA from both intra-
erythrocytic parasites and parasite DNA fragments from
the sera would be measured in this assay. PkDNA was
detected in the faeces over a longer period than urinary
PkDNA and the PkDNA obtained from blood. Parasite
DNA may enter the faeces passively via serum or within
the phagosomes of macrophages in the host’s reticuloen-
dothelial system. Another possibility is that cell-free DNA
from degraded parasites in the liver enters the faeces via
the bile. Recently, Abkallo and colleagues reported that
DNA from the pre-erythrocytic stages of rodent malaria
parasites was detectable in the liver, gall bladder and
faeces of mice following sporozoite inoculation [25]. A
particularly high concentration of parasite DNA was
detected in the gall bladder. The authors concluded that
parasite DNA entered the faeces via the bile following its
clearance in the liver. Generally, infected erythrocytes are
degraded not only in the spleen but also in the liver during
the course of infection, and a large amount of degraded
parasite constituents, including DNA, are produced in the
liver. The degraded constituents are excreted from the
liver via the bile to the faeces over a longer period
compared to urine. It is possible that the parasite DNA is
accumulated in gall bladder following parasite clearance,
and it may be gradually excreted via the bile to the faeces.
Whereas, the parasite DNA fragment through the glom-
erulus will not remain for very long in the urinary bladder,
and it may be promptly excreted via the urine.
To date, molecular detection approaches using urine
and faeces samples have been developed targeting
several genes such as the merozoite surface protein-1
(MSP1) gene, MSP2 gene, DHFR gene, small subunit
ribosomal RNA gene (18S rRNA) and the mitochondrial
cytochrome b (cytb) gene [8-13]. Putaporntip and
colleagues demonstrated that the diagnostic perform-
ance of the cytb-PCR system using saliva and urine
could be of practical value in comparison with perform-
ing 18S rRNA gene-PCR [12]. It is thought that the
cytb-PCR system is highly sensitive, because it targets
the mitochondrial genome, multiple copies of which are
present in each parasite. Furthermore, Mharakurwa and
colleagues showed that shorter PCR amplicons are amp-
lified effectively from parasite DNA in urine and saliva
because such DNA may be highly fragmented by the
time it reaches these fluids [8]. This result has previously
also been observed with amplified human DNA derivedfrom frozen urine samples [26]. In the present study, a
131-bp sequence of the cytb gene of P. knowlesi could be
detected in urine and faeces using a specific PCR assay.
To further develop the PCR system for detection of
parasite DNA in excreta, it is necessary to consider the
target gene as well as its PCR amplicon size.
Conclusion
In conclusion, the cytb-PCR system using urine and faecal
samples is of potential use in molecular epidemiological
surveys of malaria. Caution must be taken, however, when
interpreting the results of positive amplification of malaria
parasite DNA from faeces, as Abkallo et al. demonstrated
that this could derive from liver stage parasites, and so
does not necessarily prove that a host has, or is even
susceptible to, a blood infection with these parasites [25].
Bearing this in mind, faecal samples could be useful for
the detection of zoonotic primate malaria in its natural
hosts. These findings, therefore, emphasize the potential
usefulness of the cytb-PCR system using urine and faeces
as a tool for the surveillance of P. knowlesi infection in the
field.
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